Criteria of Silva et al for Therapeutic Response in Patients with Schistosomal Myeloradiculopathy (SMR)

Description

Silva et al developed criteria for therapeutic response seen in patients with schistosomal myeloradiculopathy (SMR). These can help compare the effectiveness of different treatment protocols. The authors are from the Federal University of Minas Gerais and Sarah Kubitscheck Hospital in Brazil.

Outcome to Therapy	Classification
complete improvement in neurologic status	full recovery
clinical improvement with minor defects that do not interfere with activities of daily living	partial recovery without functional limitation
clinical improvement with the presence of (a) permanent disabling weakness, (b) severe urinary dysfunction, (c) severe intestinal dysfunction, and/or (d) sensory loss	partial recovery with functional limitation
no change in clinical status	no recovery

where:

• Disabling weakness may include the inability to ambulate without help.

• Urinary dysfunction indicates urinary retention or incontinence.

• Intestinal dysfunction indicates fecal retention (constipation) or incontinence.

• The classification needs a category for clinical progression or deterioration.

To read more or access our algorithms and calculators, please log in or register.

Description

Specialty

ICD-10